Thomas Moll

Eli Lilly (United States) — United States

Immunology and Microbiology · Life Sciences

33h-index4.5kcitations84works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(18), T-cell and B-cell Immunology(15), Cell Adhesion Molecules Research(15), Immune Response and Inflammation(7), Monoclonal and Polyclonal Antibodies Research(7)

Publications84 total

The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)
Calcified Tissue International·2021· 12 citedOpen Access
The Effect of Teriparatide Treatment on the Risk of Clinical Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)
Bursa Uludag University - AVESIS·2020
Design And Baseline Characteristics Of Population Enrolled In Multinational, Observational Study Of Teriparatide
Osteoporosis and Sarcopenia·2018Open Access
Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS)
Current Medical Research and Opinion·2018· 16 citedOpen Access
Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxis
Allergy and Asthma Proceedings·2018· 2 cited
Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)
Calcified Tissue International·2018· 39 citedOpen Access
Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector
Annals of Allergy Asthma & Immunology·2018· 8 citedOpen Access
Human Factors Study of a Newly Approved Epinephrine Prefilled syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis
Journal of Allergy and Clinical Immunology·2018Open Access
Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)
Calcified Tissue International·2016· 52 citedOpen Access
A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer
Investigational New Drugs·2016· 10 cited
Phase 1/2a, open-label, dose-escalation and safety study of APC-100 in men with advanced prostate cancer.
Journal of Clinical Oncology·2015
Local anaesthetic toxicity: are we prepared for the consequences in the Emergency Department?
Emergency Medicine Journal·2010· 11 cited
<i>In vivo</i> over‐expression of interleukin‐10 increases resistance to focal brain ischemia in mice
Journal of Neurochemistry·2009· 137 cited
Protection of Murine Systemic Lupus by the <i>Ea</i> Transgene without Expression of I-E Heterodimers
The Journal of Immunology·2008· 3 citedOpen Access
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function
The Journal of Experimental Medicine·2007· 123 citedOpen Access
CD8+ T Cells Resistant to Costimulatory Blockade Are Controlled by an Antagonist Interleukin-15/Fc Protein
Transplantation·2006· 14 citedOpen Access
Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-γ production and cross-strain reactivity
Clinical & Experimental Immunology·2006· 7 citedOpen Access
Contribution of NZB Autoimmunity 2 to Y-Linked Autoimmune Acceleration-Induced Monocytosis in Association with Murine Systemic Lupus
The Journal of Immunology·2006· 39 citedOpen Access
An Antagonist Mutant IL-15/Fc Promotes Transplant Tolerance
Transplantation·2006· 32 cited
Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding
International Immunology·2005· 18 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Shozo Izui(13), Liliane Fossati‐Jimack(8), Kim Nasmyth(7), Dietmar Vestweber(7), Shuichi Kikuchi(6), Hirofumi Amano(6), Eduardo Martínez-Soria(6), Marie‐Laure Santiago‐Raber(6), Eri Amano(5), Renate Hofer-Warbinek(4), Fritz H. Bach(4), Terry B. Strom(4), Lars Nitschke(4), Brian L. Kotzin(4), Manfred Neuberg(3), Ruth Eytner(3), Samareh Azeredo da Silveira(3), Xin Xiao Zheng(3), Fernando Marín(3), Akinori Ida(3)